Jagadeswara Rao Earla
8PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Nov 04, 2025
Factors influencing Patient Preferences for BRCA Testing and Adjuvant Therapy in HER2-Negative Early Breast Cancer in the United States: Best-Worst Scaling and Discrete Choice Experiment.Kathryn Mishkin, Qixin Li, Jagadeswara Rao Earla
|Aug 22, 2025
Patient characteristics, treatment patterns, and clinical outcomes in HER2-negative early breast cancer by germline BRCA status.Jay A Andersen, Jagadeswara Rao Earla, Nicole Fulcher
|Dec 16, 2024
Correlation Between Disease-Free Survival Endpoints and Overall Survival in Elderly Patients with Early-Stage HER2-Negative Breast Cancer: A SEER-Medicare Analysis.Jagadeswara R Earla, Allison W Kurian, Kalé Kponee-Shovein
|Dec 09, 2024
Real-world perioperative treatment patterns and economic burden of recurrence in early-stage HER2-negative breast cancer: a SEER-Medicare study.Jagadeswara Rao Earla, Kalé Kponee-Shovein, Allison W Kurian
|May 09, 2023
Comparative adherence trajectories of oral disease-modifying agents in multiple sclerosis.Jagadeswara Rao Earla, Jieni Li, George J Hutton
|Feb 28, 2021
Comparative treatment effectiveness of oral fingolimod and conventional injectable disease-modifying agents in multiple sclerosis.Jagadeswara R Earla, George J Hutton, Douglas J Thornton
Pageof 2
Frequent Collaborators
3 joint publications
Rajender R Aparasu
2 joint publications
J Douglas Thornton
2 joint publications
Hua Chen
2 joint publications
Kim M Hirshfield
1 joint publications
Kalé Kponee-Shovein
1 joint publications
Allison W Kurian
1 joint publications
Jaime A Mejia
1 joint publications
Kathryn Krupsky
1 joint publications
Kathleen Beusterien
1 joint publications
Ryan Honomichl
